The findings have cast doubt over any potential expansion of the Medical Cannabis Access Programme (MCAP).
The study is said to 'lay the foundations' for for further research to explore cannabis as a treatment for Long COVID symptoms.
Researchers found no short-term increase in health service use or frequency of psychotic disorders.
Medical cannabis associations have called for the approval requirement to be scrapped for all conditions.
We asked experts in the European cannabis sector about their predictions for 2024.
65% of respondents said they thought medical cannabis should be available on the NHS.
Medical cannabis was rated as more positive in terms of emotional and holistic effects.
Leaders have assured patients that all aspects of operations, services, and leadership will remain unchanged.
Patients showed improvements in sleep, anxiety and overall quality of life.
The new partners will help to secure the future of the project.